Latest filing published 03 Sept 2026 for Neurocrine Biosciences INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Stephen A. Sherwin across 2 companies, led by Neurocrine Biosciences Inc and Biogen Inc. In total, 20 filings cover trades dated from 7 April 2015 to 2 September 2026.
On the market, this insider has only sold: 2 sales, €2.8M in total. Outside the open market, there are 7 share grants and 6 option exercises.
The record was last updated on 3 September 2026 with a transaction in Neurocrine Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations